No abstract available
Keywords:
Bone turnover markers; Denosumab; Osteoporosis; Vertebral fractures; Vertebroplasty; Women.
MeSH terms
-
Bone Density
-
Bone Density Conservation Agents* / adverse effects
-
Denosumab* / adverse effects
-
Humans
-
Osteoporosis, Postmenopausal* / diagnostic imaging
-
Osteoporosis, Postmenopausal* / drug therapy
-
Osteoporotic Fractures* / prevention & control
-
Spinal Fractures* / chemically induced
-
Spinal Fractures* / diagnostic imaging
Substances
-
Bone Density Conservation Agents
-
Denosumab